Back to Woodline Partners LP Woodline Partners LP

IMNMIMNM
Showing 8 of 11 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in IMMUNOME INC

Yes. Woodline Partners holds 1,000,398 shares of IMNM (Immunome), worth $21.2M, as of its Q2 2026 13F filing. It reduced the position by 575,000 shares (-36.5%) from Q1 2026. Woodline Partners has held IMNM since Q4 2023, across 11 quarterly 13F filings. IMNM is 0.1% of Woodline Partners' reported 13F portfolio.

Current Value

$21.2M

Current Shares

1M

Total Value Change

+$7.7M

Total Shares Change

+76,006

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1M
-36.5%
$21.2M0.1%$21.19
0
2026-Q1
Unchanged
1.6M
0.0%
$34.5M0.1%$21.87
0
2025-Q4
Increased
1.6M
+23.6%
$33.8M0.1%$21.48
42
2025-Q3
Decreased
1.3M
-23.1%
$14.9M0.1%$11.71
0
2025-Q2
Increased
1.7M
+0.1%
$15.4M0.1%$9.30
28
2025-Q1
Increased
1.7M
+69.0%
$11.2M0.1%$6.73
41
2024-Q4
Increased
980,925
+6.1%
$10.4M0.1%$10.62
29
2024-Q3
Increased
924,392
+0.2%
$13.5M0.1%$14.62
33

Other major holders of IMNM: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used